You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatobiliary disorders

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatobiliary Disease, Hepatobiliary Disorders, Surgical Site Infection Trial in Karachi (Negative Pressure Wound Therapy)

Completed
  • Hepatobiliary Disease
  • +2 more
  • Negative Pressure Wound Therapy
  • Karachi, Sindh, Pakistan
    Sindh Institute of Urology and Transplantation
Jul 28, 2022

Upper Gastrointestinal Disorders, Lower Gastrointestinal Disorders, Hepatobiliary Cancer Trial in Southampton (Cardiopulmonary

Recruiting
  • Upper Gastrointestinal Disorders
  • +2 more
  • Cardiopulmonary exercise test
  • Southampton, United Kingdom
    University Hospitals Southampton
Oct 31, 2022

Hepatic and Hepatobiliary Disorders Trial in Roma (Indocyanine green)

Recruiting
  • Hepatic and Hepatobiliary Disorders
  • Indocyanine green
  • Roma, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Mar 1, 2022

Hepatobiliary Disorders, Non-alcoholic Fatty Liver Disease Trial in Mainz, Neuss (Semaglutide, Placebo)

Completed
  • Hepatobiliary Disorders
  • Non-alcoholic Fatty Liver Disease
  • Mainz, Germany
  • +1 more
Nov 12, 2021

Ophthalmology, Artificial Intelligence, Hepatobiliary Disease Trial in Guangzhou (Hepatobiliary Disorders)

Completed
  • Ophthalmology
  • +2 more
  • Hepatobiliary Disorders
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity
Aug 16, 2020

Bowel Obstruction, Bowel Ischemia, Diverticulitis Trial in Berlin (ICG-NIRF Imaging plus ingress and egress analysis)

Recruiting
  • Bowel Obstruction
  • +11 more
  • ICG-NIRF Imaging plus ingress and egress analysis
  • Berlin, Germany
    Charité Campus Benjamin Franklin
Jan 13, 2021

Social Determinants of Health in Hepatobiliary Cancer Patients

Recruiting
  • Malignant Hepatobiliary Neoplasm
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 22, 2023

Coronary Artery Disease Trial in Japan (Device: Paclitaxel-Coated PTCA Balloon Catheter, SeQuent Please Drug Eluting Balloon

Active, not recruiting
Has Results
  • Coronary Artery Disease
  • Device: Paclitaxel-Coated PTCA Balloon Catheter
  • SeQuent Please Drug Eluting Balloon Catheter with Paclitaxel
  • Kitakyushu, Fukuoka, Japan
  • +13 more
Dec 2, 2022

Hepatobiliary Cancer, Cholangiocarcinoma, Liver Metastases Trial in Tampa (Resistance Training, Aerobic Training)

Recruiting
  • Hepatobiliary Cancer
  • +2 more
  • Resistance Training
  • Aerobic Training
  • Tampa, Florida
    Moffitt Cancer Center
Jun 16, 2023

Hepatocellular Carcinoma, Biliary Tract Cancer Trial in Worldwide (MEDI5752, Bevacizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Biliary Tract Cancer
  • Birmingham, Alabama
  • +44 more
Mar 17, 2023

Hepatic Cancer Trial in New York (FLOXURIDINE)

Completed
Has Results
  • Hepatic Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 29, 2021

Obesity Trial in Seattle (behavioral lifestyle intervention)

Completed
Has Results
  • Obesity
  • behavioral lifestyle intervention
  • Seattle, Washington
    VA Puget Sound Health Care System Seattle Division, Seattle, WA
Nov 4, 2022

Courses of Hepatobiliary Manifestations After Proctocolectomy

Completed
  • Hepatobiliary Disease
  • laparoscopic restorative proctocolectomy
  • (no location specified)
Aug 12, 2022

Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Trial in Worldwide (lanreotide, Placebo)

Terminated
Has Results
  • Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
  • Bruxelles, Belgium
  • +23 more
Dec 21, 2022

Gout Trial in Taipei (Placebo, AC-201, Febuxostat)

Completed
Has Results
  • Gout
  • Placebo
  • +2 more
  • Taipei, Taiwan
    Taipei Veteran General Hospital (TVGH)
Jun 2, 2022

HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)

Terminated
Has Results
  • HIV-1-infection
  • Edmonton, Alberta, Canada
    University of Alberta
Nov 21, 2022

Hepatitis D, Chronic Trial in Israel, New Zealand, Pakistan (Peginterferon Lambda-1A)

Completed
Has Results
  • Hepatitis D, Chronic
  • Peginterferon Lambda-1A
  • Beersheba, Israel
  • +3 more
Dec 20, 2022

Hepatobiliary Cancer, Liver Cancer Trial (Zimberelimab, Domvanalimab)

Not yet recruiting
  • Hepatobiliary Cancer
  • Liver Cancer
  • (no location specified)
Feb 2, 2023

Therapeutic Assistance and Decision-making Algorithms in

Not yet recruiting
  • Hepatocellular Carcinoma
  • +5 more
  • ADBoard
  • Berlin, Germany
    Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Jan 12, 2023

Detection of Jaundice From Ocular Images Via Deep Learning

Active, not recruiting
  • Ophthalmology
  • +2 more
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Jan 10, 2023

    Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

    Active, not recruiting
    Has Results
    • Cholangiocarcinoma
    • +6 more
    • Laboratory Biomarker Analysis
    • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
    • Scottsdale, Arizona
    • +1 more
    Jan 4, 2023

    COVID-19, COVID Trial in Boston (Pegylated interferon lambda)

    Terminated
    Has Results
    • COVID-19
    • COVID
    • Pegylated interferon lambda
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jun 29, 2022

    Breast - Female, Male Breast Cancer Trial in Charlotte (Pembrolizumab, Paclitaxel)

    Completed
    Has Results
    • Breast - Female
    • Male Breast Cancer
    • Charlotte, North Carolina
      Levine Cancer Institute
    Jan 25, 2023

    Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial in Chicago

    Terminated
    Has Results
    • Pancreatic Adenocarcinoma
    • +2 more
    • Pembrolizumab
    • Wild-type Reovirus
    • Chicago, Illinois
      Northwestern University
    Sep 6, 2022

    Advanced Liver Cancers, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

    Recruiting
    • Advanced Liver Cancers
    • +4 more
    • Tumor Infiltrating Lymphocyte
    • Shanghai, Shanghai, China
      Shanghai Tenth People's Hospital
    Dec 19, 2022